ABPI

News

Pharma urges NHS to put medicines at heart of 10-year plan

The UK pharma industry has warned that declining access to new medicines in England will undermine the government's efforts to rebuild the NHS.

News

HCP in lab coat holding a red stethoscope

UK 'needs more transparency on pharma-doctor payments'

The UK's system of disclosing payments from pharma to healthcare professionals has gaps that hide potential conflicts of interest, claims study.

News

MHRA's stature undermined by lack of resources says pharma

The MHRA isn't sufficiently funded to meet its obligations and that could threaten UK investment in life sciences, according to an ABPI report.

Market Access

Moderna’s missteps spotlight PMCPA’s role in upholding pharm...

The pharmaceutical industry operates under a complex regulatory landscape, balancing government oversight with self-imposed standards.

Market Access

Progress with the UK’s VPAG

Leela Barham looks at the first operational review meeting minutes that have been published on the VPAG, the UK’s latest scheme on branded medicines pricing and access, building on previous

Market Access

Metrics for the UK’s VPAG: A work in progress

Just as for previous schemes, metrics are being used to track VPAG, the UK’s voluntary scheme that covers branded medicines pricing and access.

Pharma urges NHS to put medicines at heart of 10-year plan

UK 'needs more transparency on pharma-doctor payments'

MHRA's stature undermined by lack of resources says pharma

Moderna’s missteps spotlight PMCPA’s role in upholding pharm...

Progress with the UK’s VPAG

Metrics for the UK’s VPAG: A work in progress

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

ABPI

Editor's Picks